Check out our most popular compounded medications! Get Started
Bayview Pharmacy's EGCG 1%/Imiquimod 1% Topical Gel is a semisolid formulation dispensed through a pump mechanism. This design allows for easy and precise application on the skin, targeting the treatment or absorption of active ingredients in a gel-like consistency. It is a compounded medication used to treat Actinic Keratosis, Basal Cell Carcinoma, Squamous Cell Carcinoma, Bowen's Disease, and Melanoma.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
EGCG 1%/Imiquimod 1% Topical Gel is a specially compounded medication designed to treat a range of skin conditions, including Actinic Keratosis, Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma, and Bowen's Disease.
EGCG, a polyphenol found in green tea, is known for its anti-inflammatory and antioxidant properties. These properties can help to reduce inflammation and protect the skin from oxidative stress, which can contribute to the development of various skin conditions. Imiquimod, on the other hand, is an immune response modifier that has been successfully used in the treatment of a variety of skin conditions, including actinic keratosis, basal cell carcinoma, squamous cell carcinoma, melanoma, and Bowen's disease.
This semisolid formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment or absorption of active ingredients in a gel-like consistency. It is designed to be applied topically to the affected area and is generally well tolerated. However, it is important to note that this medication should not be used on broken or irritated skin. Always follow the instructions provided by your healthcare provider when using this medication to ensure its effectiveness and safety.
At Bayview Pharmacy, our team of compounding pharmacists is committed to providing the highest quality compounded medications to our patients. We understand the unique needs of each patient and work diligently to provide personalized medication solutions. If you have any questions about EGCG 1%/Imiquimod 1% Topical Gel or any other compounded medications, please do not hesitate to reach out to us. We are here to assist you with your healthcare needs.
This EGCG 1%/Imiquimod 1% Topical Gel is a compounded formulation designed for the treatment of various skin conditions including Actinic Keratosis, Basal Cell Carcinoma, Squamous Cell Carcinoma, Melanoma, and Bowen's Disease. The gel is applied directly to the affected area twice daily for a period of up to 16 weeks.
Patients using this formulation should be closely monitored for any signs of skin irritation such as redness, itching, burning, or stinging. If these symptoms occur, it is recommended that the patient discontinues use and contacts their healthcare provider immediately. Similarly, signs of systemic toxicity such as fever, chills, nausea, vomiting, or diarrhea should be taken seriously. If these symptoms occur, the patient should discontinue use and contact their healthcare provider.
It is also important to monitor for signs of an allergic reaction, such as rash, hives, or difficulty breathing. If these symptoms occur, the patient should discontinue use and contact their healthcare provider. Signs of an infection, such as redness, swelling, or drainage, should also be closely monitored. If these symptoms occur, the patient should discontinue use and contact their healthcare provider.
Patients should also be vigilant for signs of an adverse reaction to the medication, such as rash, hives, or difficulty breathing. If these symptoms occur, the patient should discontinue use and contact their healthcare provider. Additionally, signs of an adverse reaction to sun exposure, such as redness, itching, or burning, should be closely monitored. If these symptoms occur, the patient should discontinue use and contact their healthcare provider.
Lastly, patients should be monitored for signs of an adverse reaction to other medications, such as rash, hives, or difficulty breathing. If these symptoms occur, the patient should discontinue use and contact their healthcare provider. If you have any questions about this formulation or its use, please do not hesitate to reach out for further information.
EGCG 1%/Imiquimod 1% Topical Gel is a compounded formulation that combines the therapeutic benefits of two active ingredients, EGCG and Imiquimod, to treat a range of skin conditions. EGCG, or epigallocatechin gallate, is a potent polyphenol derived from green tea, known for its anti-inflammatory and antioxidant properties. Imiquimod, on the other hand, is an immune response modifier that aids in activating the body's natural defenses against certain skin diseases.
When applied to the affected area, the EGCG 1%/Imiquimod 1% Topical Gel works by reducing inflammation and stimulating the immune system to combat the disease. It has been shown to reduce tumor size, lower the risk of recurrence, and enhance the overall appearance of the skin.
The recommended usage for this topical gel is twice daily, and treatment should be continued until the condition has been fully resolved. However, it's important to note that EGCG 1%/Imiquimod 1% Topical Gel may cause skin irritation, redness, and itching. If these side effects occur, patients are advised to consult their healthcare provider immediately. Furthermore, patients should avoid sun exposure while using this medication, as it can exacerbate the risk of skin irritation.
Prescribers should be aware that EGCG 1%/Imiquimod 1% Topical Gel is not recommended for use in pregnant or breastfeeding women. It should also be avoided in patients with a known hypersensitivity to either of the active ingredients. If you have any questions or concerns about EGCG 1%/Imiquimod 1% Topical Gel, please do not hesitate to reach out for further information.
This is a compounded formulation of two active ingredients, EGCG and Imiquimod, each at a 1% concentration. It is a semisolid formulation that is dispensed through a pump mechanism for easy and precise application on the skin.
The EGCG 1%/Imiquimod 1% Topical Gel has a gel-like consistency. This makes it easy to apply and allows for targeted treatment or absorption of the active ingredients.
The gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin. Simply press the pump to dispense the gel and apply it to the targeted area.
The active ingredients in this topical gel are EGCG and Imiquimod, each at a 1% concentration. These ingredients are designed to be absorbed by the skin for targeted treatment.
As with any skincare product, it's recommended to do a patch test first to see how your skin reacts. If you have any concerns, please consult with your healthcare provider or pharmacist.
The frequency of use will depend on the specific instructions provided by your healthcare provider. Always follow the prescribed dosage and application instructions.
If you experience any side effects, stop using the product immediately and consult with your healthcare provider. Side effects may include redness, irritation, or an allergic reaction.
It's best to consult with your healthcare provider or pharmacist before combining this topical gel with other skincare products. They can provide guidance based on the specific ingredients and your skin type.
Yes, the pump mechanism is designed to be easy to use, allowing for precise application of the gel. Simply press the pump to dispense the gel.
The EGCG 1%/Imiquimod 1% Topical Gel is designed for targeted treatment, so it should be applied to the specific area as directed by your healthcare provider. If you have any questions about where to apply the gel, please consult with your healthcare provider or pharmacist.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
